ATE113957T1 - Immunstimulierende guaninderivate, zusammenstellungen und verfahren. - Google Patents

Immunstimulierende guaninderivate, zusammenstellungen und verfahren.

Info

Publication number
ATE113957T1
ATE113957T1 AT89304511T AT89304511T ATE113957T1 AT E113957 T1 ATE113957 T1 AT E113957T1 AT 89304511 T AT89304511 T AT 89304511T AT 89304511 T AT89304511 T AT 89304511T AT E113957 T1 ATE113957 T1 AT E113957T1
Authority
AT
Austria
Prior art keywords
compositions
methods
stimulating
immune
guanine derivatives
Prior art date
Application number
AT89304511T
Other languages
English (en)
Inventor
Michael Goodman
Robert Chen
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Application granted granted Critical
Publication of ATE113957T1 publication Critical patent/ATE113957T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT89304511T 1988-05-05 1989-05-04 Immunstimulierende guaninderivate, zusammenstellungen und verfahren. ATE113957T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/190,694 US5093318A (en) 1983-11-01 1988-05-05 Immunostimulating guanosine derivatives and their pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ATE113957T1 true ATE113957T1 (de) 1994-11-15

Family

ID=22702383

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89304511T ATE113957T1 (de) 1988-05-05 1989-05-04 Immunstimulierende guaninderivate, zusammenstellungen und verfahren.

Country Status (12)

Country Link
US (1) US5093318A (de)
EP (1) EP0341066B1 (de)
JP (1) JP2790846B2 (de)
AT (1) ATE113957T1 (de)
AU (1) AU619539B2 (de)
CA (1) CA1320196C (de)
DE (1) DE68919266T2 (de)
DK (1) DK170780B1 (de)
ES (1) ES2063125T3 (de)
GR (1) GR3015018T3 (de)
IE (1) IE66321B1 (de)
PT (1) PT90464B (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011828A (en) * 1985-11-15 1991-04-30 Michael Goodman Immunostimulating guanine derivatives, compositions and methods
US7307166B1 (en) 1987-10-28 2007-12-11 Wellstat Therapeutics Corporation Oxpurine nucleosides and their congeners, and acyl, derivatives thereof, for improvement of hematopoiesis
IE882585L (en) * 1988-08-25 1990-02-25 Prendergast Patrick T Viral treatment system
AU5165793A (en) * 1992-10-01 1994-04-26 Mcneilab, Inc. Derivatives of 7,8-disubstituted guanosines
US6727230B1 (en) * 1994-03-25 2004-04-27 Coley Pharmaceutical Group, Inc. Immune stimulation by phosphorothioate oligonucleotide analogs
US5441942A (en) * 1994-05-27 1995-08-15 The Scripps Research Institute 2'3'-dideoxy-2',3'-didehydro-7,8-disubstituted guanosines and their immunostimulative effect
US5382580A (en) * 1994-05-27 1995-01-17 The Scripps Research Institute N9 morpholino derivatives of 7,8-disubstituted guanines
US5786359A (en) * 1994-05-27 1998-07-28 The Scripps Research Institute N9 alkyl or aralkyl derivatives of 7, 8-disubstituted guanines
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
US5773424A (en) * 1994-12-16 1998-06-30 Research Corporation Technologies, Inc. Treatment of toxoplasmosis
US20030100520A1 (en) * 1997-01-21 2003-05-29 Philip Needleman Immunological process and constructs for increasing the hdl cholesterol concentration by dna vaccination
US6303617B1 (en) 1998-05-04 2001-10-16 Neotherapeutics, Inc. Serotonin-like 9-substituted hypoxanthine and methods of use
US6562801B1 (en) 1999-04-15 2003-05-13 Board Of Regents, The University Of Texas System PpGpp and pppGpp as immunomodulatory agents
US6949520B1 (en) * 1999-09-27 2005-09-27 Coley Pharmaceutical Group, Inc. Methods related to immunostimulatory nucleic acid-induced interferon
US6288069B1 (en) 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
US20010044416A1 (en) * 2000-01-20 2001-11-22 Mccluskie Michael J. Immunostimulatory nucleic acids for inducing a Th2 immune response
US7585847B2 (en) * 2000-02-03 2009-09-08 Coley Pharmaceutical Group, Inc. Immunostimulatory nucleic acids for the treatment of asthma and allergy
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
ES2385931T3 (es) 2000-07-07 2012-08-03 Spectrum Pharmaceuticals, Inc. MÉTODOS PARA EL TRATAMIENTO DE NEUROPATíA PERIFÉRICA INDUCIDA POR UNA ENFERMEDAD Y AFECCIONES RELACIONADAS.
US20030138769A1 (en) * 2000-08-16 2003-07-24 Birkett Ashley J. Immunogenic HBc chimer particles having enhanced stability
ES2307568T3 (es) * 2000-12-08 2008-12-01 Coley Pharmaceutical Gmbh Acidos nucleicos de tipo cpg y metodos de uso de los mismos.
US6759427B2 (en) * 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
US20030175863A1 (en) * 2001-08-15 2003-09-18 Birkett Ashley J. Influenza immunogen and vaccine
US7361352B2 (en) 2001-08-15 2008-04-22 Acambis, Inc. Influenza immunogen and vaccine
US20030185858A1 (en) * 2001-08-15 2003-10-02 Birkett Ashley J. Immunogenic HBc chimer particles stabilized with an N-terminal cysteine
US7351413B2 (en) * 2002-02-21 2008-04-01 Lorantis, Limited Stabilized HBc chimer particles as immunogens for chronic hepatitis
AU2004226605A1 (en) * 2003-04-02 2004-10-14 Coley Pharmaceutical Group, Ltd. Immunostimulatory nucleic acid oil-in-water formulations for topical application
DE602006003913D1 (de) * 2005-09-22 2009-01-08 Hoffmann La Roche Selektive o-acylierung von nukleosiden
EA017887B1 (ru) * 2007-08-02 2013-03-29 Байондвакс Фармасьютикалз Лтд. Полимерные мультиэпитопные вакцины против гриппа
CA2744739A1 (en) 2007-12-03 2009-06-11 President And Fellows Of Harvard College Chlamydia antigens
BRPI0922132A2 (pt) 2008-12-03 2018-10-23 Protea Vaccine Tech Ltd fragmentos glutamil trna sintetase (gts).
WO2011067758A2 (en) 2009-12-02 2011-06-09 Protea Vaccine Technologies Ltd. Immunogenic fragments and multimers from streptococcus pneumoniae proteins
WO2012114323A1 (en) 2011-02-22 2012-08-30 Biondvax Pharmaceuticals Ltd. Multimeric multiepitope polypeptides in improved seasonal and pandemic influenza vaccines
EP3492095A1 (de) 2012-04-01 2019-06-05 Technion Research & Development Foundation Limited Extrazelluläre matrix-metalloproteasen-induktor (emmprin)-peptide und bindende antikörper
JP6550072B2 (ja) 2014-04-03 2019-07-24 バイオンドバックス ファーマシューティカルズ リミテッド 多量体マルチエピトープインフルエンザポリペプチドの組成物及びそれらの生成
CA3101364A1 (en) 2018-05-25 2019-11-28 Primmune Therapeutics, Inc. Tlr7 agonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4948730A (en) * 1982-11-09 1990-08-14 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US4643992A (en) * 1982-11-09 1987-02-17 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US4539205A (en) * 1982-11-09 1985-09-03 Scripps Clinic And Research Foundation Modulation of animal cellular responses with compositions containing 8-substituted guanine derivatives
US5011828A (en) * 1985-11-15 1991-04-30 Michael Goodman Immunostimulating guanine derivatives, compositions and methods

Also Published As

Publication number Publication date
EP0341066A2 (de) 1989-11-08
DE68919266T2 (de) 1995-06-01
IE66321B1 (en) 1995-12-27
AU619539B2 (en) 1992-01-30
JP2790846B2 (ja) 1998-08-27
EP0341066B1 (de) 1994-11-09
US5093318A (en) 1992-03-03
JPH0256496A (ja) 1990-02-26
DE68919266D1 (de) 1994-12-15
ES2063125T3 (es) 1995-01-01
DK217289A (da) 1989-11-06
DK170780B1 (da) 1996-01-15
PT90464A (pt) 1989-11-30
CA1320196C (en) 1993-07-13
PT90464B (pt) 1994-12-30
EP0341066A3 (en) 1990-05-30
IE891463L (en) 1989-11-05
AU3399989A (en) 1989-11-09
DK217289D0 (da) 1989-05-03
GR3015018T3 (en) 1995-05-31

Similar Documents

Publication Publication Date Title
ATE113957T1 (de) Immunstimulierende guaninderivate, zusammenstellungen und verfahren.
ATE109155T1 (de) Immunstimulierende guaninderivate, zusammenstellungen und verfahren.
PT88401A (pt) Improvements relating to smoking articles
LV5264A3 (lv) Panemiens guanina atvasinajumu vai to farmaceitiski pielietojamu skabju-aditivo saju iegusanai
PT88399A (pt) Improvements relating to smoking articles
ATE133858T1 (de) Verwendung von monoolein bei der behandlung der periodontal- tasche
DE69110854D1 (de) Antivirusderivate von (Phosphonmethoxy)Methoxy Purin/Pyrimidin.
DK209187A (da) Anvendelse af adenosin-derivater til behandling af demens
FI895447A7 (fi) Substituoidut terapeuttisina aineina käytettävät adeniinijohdannaiset
FI930192A7 (fi) Puriinien virusvastaiset fosfonoalkeenijohdannaiset
FI924478A0 (fi) 24-oxa-derivat i vitamin d-serien
NO178497C (no) Fremgangsmåte for fremstilling av 9-substituerte guaninderivater og mellomprodukter for anvendelse i fremgangsmåten
ATE67203T1 (de) 9-deazaquanine.
FI932759A7 (fi) IL-4:n käyttö rokotteiden immunogeeneihin kohdistuvan immuunireaktion lisäämiseksi
IT8868117A0 (it) Solfonammidi di benzilidene canfora derivanti da amminoacidi e loro impiego in cosmesi particolarmente come filtri solari
GR3023611T3 (en) Penciclovir and famciclovir and related guanine derivatives for the treatment of the hiv-1 infections
ITMI920886A1 (it) Impiego di oligouretani come agenti di formazione per preparati di pigmenti acquosi
FI911310A7 (fi) Substituoidut puriinit, menetelmä niiden valmistamiseksi, sekä niiden käyttö antiviraalisina aineina
DE3750642D1 (de) Verfahren und Zusammensetzungen betreffend regressions-assoziierte Antigene.
ATE36718T1 (de) Glykosaminoglykane verwendbar in kosmetologie.
FI893233A7 (fi) THAZ-johdannaisia aivotoiminnan parantamiseksi
GR1001006B (el) Μεθοδος παρασκευης και χρησιμοποιησεως αντιιικων η αντιβακτηριακων συνθεσεων.
IT1222553B (it) Derivati dell' s-carbossimetilcisteina

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee